Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | HPGD | P15428 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.44 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CDC25B | P30305 | 2/20 | 0.42 |
| ▸ | LDHA | P00338 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.41 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.41 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.41 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.40 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5411002 | 0.84 | KDM4E (0.43) | MEN1KMT2AHPGDALDH1A1HSD17B10 | |
| SCHEMBL5032934 | 0.76 | TRPM4 (0.48) | MEN1KMT2AHPGDALDH1A1HSD17B10 | |
| SCHEMBL29019737 | 0.71 | TRPM4 (0.43) | MEN1KMT2AHPGDALDH1A1HSD17B10 | |
| SCHEMBL7628474 | 0.70 | ERN1 (0.42) | MEN1KMT2AHPGDALDH1A1HSD17B10 | |
| SCHEMBL9770151 | 0.70 | MEN1 (0.50) | MEN1KMT2AHPGDALDH1A1HSD17B10 | |
| SCHEMBL770722 | 0.69 | CYP1A2 (0.70) | MEN1KMT2AHPGDALDH1A1HSD17B10 | |
| SCHEMBL2517773 | 0.69 | NR4A1 (0.48) | MEN1KMT2AHPGDALDH1A1HSD17B10 | |
| SCHEMBL6631799 | 0.69 | CYP2D6 (0.47) | MEN1KMT2AHPGDALDH1A1HSD17B10 | |
| SCHEMBL6461 | 0.68 | ACMSD (0.39) | MEN1KMT2AHPGDALDH1A1HSD17B10 | |
| SCHEMBL245378 | 0.68 | CYP1A2 (0.62) | MEN1KMT2AHPGDALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130122073-A1 | COMPOSITION IN THE FORM OF LIQUID FOR MAINTENANANCE OF CONTACT LENSES AND MEDICAL MATERIALS | UNIWERSYTET JAGIELLONSKI (PL) | 2013-05-16 | — | — | US | claimed |
| EP-2563148-A1 | COMPOSITION IN THE FORM OF LIQUID FOR MAINTENANCE OF CONTACT LENSES AND MEDICAL MATERIALS | Uniwersytet Jagiellonski (PL) | 2013-03-06 | — | — | EP | claimed |
| US-20120071428-A1 | NANOCRYSTALLINE PHOTOCATALYTIC COLLOID, A METHOD OF PRODUCING IT AND ITS USE | JAGIELLONIAN UNIVERSITY (PL) | 2012-03-22 | — | — | US | claimed |
| EP-2421644-A2 | NANOCRYSTALLINE PHOTOCATALYTIC COLLOID, A METHOD OF PRODUCING IT AND ITS USE | Uniwersytet Jagiello Ski (PL) | 2012-02-29 | — | — | EP | claimed |
| WO-2011136672-A1 | COMPOSITION IN THE FORM OF LIQUID FOR MAINTENANCE OF CONTACT LENSES AND MEDICAL MATERIALS | Uniwersytet Jagielloński (PL) | 2011-11-03 | — | — | WO | claimed |
| WO-2010098687-A2 | NANOCRYSTALLINE PHOTOCATALYTIC COLLOID, A METHOD OF PRODUCING IT AND ITS USE | Uniwersytet Jagielloński (PL) | 2010-09-02 | — | — | WO | claimed |
| EP-2421644-B1 | NANOCRYSTALLINE PHOTOCATALYTIC COLLOID, A METHOD OF PRODUCING IT AND ITS USE | UNIV JAGIELLONSKI (PL) | 2019-07-17 | — | — | EP | disclosed |
| EP-3089818-B1 | A VISIBLE-LIGHT-ACTIVATED MULTILAYERED PHOTOCATALYST AND THE METHOD OF ITS PREPARATION | UNIV JAGIELLONSKI (PL) | 2018-05-23 | — | — | EP | disclosed |
| US-20170001183-A1 | Visible-Light-Activated Multilayered Photocatalyst And The Method Of Its Preparation | UNIWERSYTET JAGIELLONSKI (PL) | 2017-01-05 | — | — | US | disclosed |
| EP-3089818-A2 | A VISIBLE-LIGHT-ACTIVATED MULTILAYERED PHOTOCATALYST AND THE METHOD OF ITS PREPARATION | Uniwersytet Jagiellonski (PL) | 2016-11-09 | — | — | EP | disclosed |
| EP-2563148-B1 | COMPOSITION IN THE FORM OF LIQUID FOR MAINTENANCE OF CONTACT LENSES AND MEDICAL MATERIALS | UNIV JAGIELLONSKI (PL) | 2016-08-24 | — | — | EP | disclosed |
| US-9040489-B2 | Nanocrystalline photocatalytic colloid, a method of producing it and its use | JAGIELLONIAN UNIVERSITY (PL) | 2015-05-26 | — | — | US | disclosed |
| US-20130122073-A1 | COMPOSITION IN THE FORM OF LIQUID FOR MAINTENANANCE OF CONTACT LENSES AND MEDICAL MATERIALS | UNIWERSYTET JAGIELLONSKI (PL) | 2013-05-16 | — | — | US | disclosed |
| EP-2563148-A1 | COMPOSITION IN THE FORM OF LIQUID FOR MAINTENANCE OF CONTACT LENSES AND MEDICAL MATERIALS | Uniwersytet Jagiellonski (PL) | 2013-03-06 | — | — | EP | disclosed |
| US-20120071428-A1 | NANOCRYSTALLINE PHOTOCATALYTIC COLLOID, A METHOD OF PRODUCING IT AND ITS USE | JAGIELLONIAN UNIVERSITY (PL) | 2012-03-22 | — | — | US | disclosed |
| EP-2421644-A2 | NANOCRYSTALLINE PHOTOCATALYTIC COLLOID, A METHOD OF PRODUCING IT AND ITS USE | Uniwersytet Jagiello Ski (PL) | 2012-02-29 | — | — | EP | disclosed |
| WO-2011136672-A1 | COMPOSITION IN THE FORM OF LIQUID FOR MAINTENANCE OF CONTACT LENSES AND MEDICAL MATERIALS | Uniwersytet Jagielloński (PL) | 2011-11-03 | — | — | WO | disclosed |
| US-20100323202-A1 | USE OF CARBOXYLIC ACID HYDRAZIDE FOR DE-BONDING POLYURETHANE ADHESIVES | SIKA TECHNOLOGY AG (CH) | 2010-12-23 | — | — | US | disclosed |
| US-20100273924-A1 | CURABLE COMPOSITIONS HAVING LESS VOLATILIZATION | SIKA TECHNOLOGY AG (CH) | 2010-10-28 | — | — | US | disclosed |
| WO-2010098687-A2 | NANOCRYSTALLINE PHOTOCATALYTIC COLLOID, A METHOD OF PRODUCING IT AND ITS USE | Uniwersytet Jagielloński (PL) | 2010-09-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071428-A1 | NANOCRYSTALLINE PHOTOCATALYTIC COLLOID, A METHOD OF PRODUCING IT AND ITS USE | UROD, CRYZ, CRYAB | MEN1 1615/4885KMT2A 3369/4885HPGD 3914/4885 |
| US-20130122073-A1 | COMPOSITION IN THE FORM OF LIQUID FOR MAINTENANANCE OF CONTACT LENSES AND MEDICAL MATERIALS | MLEC, CRYZ, LAGE3 | MEN1 262/4885KMT2A 1127/4885HPGD 1510/4885 |
| US-20100273924-A1 | CURABLE COMPOSITIONS HAVING LESS VOLATILIZATION | CA4, CTH, CA6 | MEN1 1018/4885KMT2A 294/4885HPGD 2018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.